Initiating Coverage on Society Pass (SOPA).

Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley NEW YORK, NY, Jan. 24, 2023 (GLOBE...

Report: Kerrisdale Capital on Up Fintech Holding (TIGR).

The Robinhood of China? If They Liked it at $18, They've got to Love it at $4.00! LIVE QUOTE Older report (February 2021), but the basic...
Mitesco

Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165% Potential Gain.

LIVE QUOTE Original Report: Initiating Coverage on Mitesco (MITI) FKA True Nature Holdings (TNTY) $0.02. Adding to Watch List. Mitesco, Inc. (MITI) is building a better...
Revive Therapeutics

Revive Therapeutics (RVVTF, RVV): Updates and News Archive.

Recent Headlines (See FDA Filing Submission at Bottom) LIVE QUOTE NEWS ARCHIVE INTRO “These medicines have a sweet spot. If the day you get diagnosed with COVID you...
CPRE Networks

Adding VYRE Network (CAPV) to the Watch List.

Look What We Found. Our First Internet Play in Ages, And It's a Doozy. We would categorize this under 'future Reddit play.' Just remember...
omniq

OMNIQ (OMQS) Graduates to NASDAQ. And Three Wall Street Research Reports Follow.

Wall Street Brokerage Price Target Estimates of $15 - $18 Per Share. Without disrupting legacy sales - CEO Shai Lustgarten's new strategy's success are readily...
Ehave, Psychedelic Stock Review

Report: Ehave Inc (EHVVF) Our Favorite Psychedelic Company

WE LOOKED FAR AND WIDE TO FIND OUR FAVORITE What exactly is a favorite? First what it isn’t. In early August our research team conducted...

Citius Pharma (CTXR) $2.15. Price Target of $8.00 Maintained, Post Safety and Efficacy Review.

Investment Banker Buy Rating Maintained: DSMB Gives the Thumbs Up – Data in Early 2022. CITIUS NEWS ARCHIVE Citius announced that the DMC interim safety and...

Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next Success Story in...

New Report on Revive Therapeutics (RVVTF, RVV). Ushering in Advances in Anti-Inflammatory and Antioxidant Drugs, as a Tool Against Covid. Early Bird Gets the Worm? Here's...
@alanliverin

Bitcoin $30,000. Time to Bargain Hunt? Read This First.

The Bit Short: Inside Crypto’s Doomsday Machine Scary article on Tether/Bitcoin posted on Medium. This is the story of a Bitcoin trade — the most financially...

Latest article

When Secure Communications is Absolutely Paramount to Mission Success.

Sekur (SWISF) $0.05 Headed to Huge Special Ops Military Convention in Tampa FL. Will Demonstrate it's "SekurVoice" Solution, to Special Ops Buyers, Designed for...

Cabaletta (CABA) Surges 44% on Massive Volume Spike.

Biotech 12 Pack Off to Nice Start.. Cabaletta up 35%, GeoVax up 75%, and Replimune up 62%. All since late April! Biotech Stock Review is...

GeoVax (GOVX) Surges 51% on Massive Volume Spike.

MonkeyPox and Gedeptin Related News Spark New Investor Interest. MARKET BRIEF On a quiet Wednesday afternoon, the 29th, while we were nearing completion of an updated...